Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
07/2005
07/13/2005CN1637625A Organophotoreceptor with a charge transport material having two epoxidated-hydrazone groups
07/13/2005CN1636993A Process for producing novel form of paroxetine hydrochloride anhydrate
07/13/2005CN1636992A Process for producing quinazoline ditosylate salt compounds
07/13/2005CN1636986A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636985A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636984A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636983A Substituted heterocyclic compounds
07/13/2005CN1636977A 1, 3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
07/13/2005CN1210274C Piperazine and piperidine derivatives
07/13/2005CN1210268C (Cyclo) alkyl substituted-gamma-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders
07/13/2005CN1210029C Pharmaceutical use for piperine and method for cosmetically promoting the natural coloration of the skin
07/12/2005US6916957 Antiinflammatory agents; antihistamines; antiallergens
07/12/2005US6916932 Such as (3S,6S,7R,8R)-8-benzyl-3-(((3-(benzyloxy)-4-methoxypyridin-2 -yl)carbonyl)amino)-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl-2-methylpropanoate for fungicides
07/12/2005US6916926 Process for the preparation of (±) 1-3-dioxolanes and the optical resolution thereof
07/12/2005US6916850 Pyruvate derivatives
07/12/2005US6916847 Anticoagulants; thrombosis; cardiovascular disorders
07/12/2005US6916841 Inhibitors of phospholipase enzymes
07/12/2005US6916830 Substituted tetrahydroisoquinolines as C5a receptor modulators
07/12/2005US6916819 Benzimidazole and pyridylimidazole derivatives
07/12/2005US6916814 Methods of treating cytokine mediated diseases
07/12/2005US6916813 (1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase
07/12/2005US6916812 Dietetic agents
07/12/2005US6916809 Heterocyclic acridone inhibitors of IMPDH enzyme
07/12/2005US6916804 Pyrimidine A2b selective antagonist compounds, their synthesis and use
07/12/2005US6916798 Inhibitors of glycogen synthase kinase-3 (GSK-3), a serine/threonine protein kinase; for treatment and prevention of diabetes and Alzheimer's disease
07/07/2005WO2005061519A1 Kinase inhibitors
07/07/2005WO2005061487A1 Hiv protease inhibiting compounds
07/07/2005WO2005061484A1 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof
07/07/2005WO2005061483A2 Modulators of peripheral 5-ht receptors
07/07/2005WO2005061482A1 Ecstasy haptens and immunogens
07/07/2005WO2005061477A1 Biaryl sulfonamides as mmp inhibitors
07/07/2005WO2005061467A2 Piperazine derivatives as bradykinin antagonists
07/07/2005WO2005061458A2 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
07/07/2005WO2005061450A2 Hiv protease inhibiting sulfonamides
07/07/2005WO2005061442A1 Opioid receptor antagonists
07/07/2005WO2005060970A1 Pyrimidines with tie2 (tek) activity
07/07/2005WO2005060969A1 Pyrimidines with tie2 (tek) activity
07/07/2005WO2005060963A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
07/07/2005WO2005060663A2 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis
07/07/2005WO2005047257A3 Methods and compositions for selectin inhibition
07/07/2005WO2005042521A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
07/07/2005WO2005037779A3 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
07/07/2005WO2005032471A3 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
07/07/2005WO2004098516A3 Cyclic derivatives as modulators of chemokine receptor activity
07/07/2005WO2004082822A3 Methods for isolating crystalline form i of 5-azacytidine
07/07/2005WO2003063771A3 N4-acylcytosine nucleosides for treatment of viral iinfections
07/07/2005WO2003053360A3 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
07/07/2005US20050148778 One pot, industrial scale, low cost synthesis; forming diazonium salt of 4-[1,2,4]triazol-1ylmethyl-aniline HCL, reducing, acidifying; reacting intermediate with keto-valerolactone then fischer indole converting followed by transesterification, amination, saponification decarboxylation
07/07/2005US20050148777 (2R)-6-chloro-7-isobutyl-2-(trifluoromethyl)-2H-chromene-3-carboxylic acid; cyclooxygenase-2 mediated disorders
07/07/2005US20050148657 9, 10-Alpha, alpha-OH-taxane analogs and methods for production thereof
07/07/2005US20050148650 protein kinase B activating agents for preventing or treating depression, PTSD, Parkinson's disease, Alzheimer's diseases, and the like; comprises for e.g. [1] 2-[2,2,4,6,7-pentamethyl-3-(4-methylphenyl)-2,3-dihydro-1-benzofuran-5-yl]isoindoline
07/07/2005US20050148646 Dicationic triaryl analogs as anti-protozoan agents
07/07/2005US20050148645 Improved solubility in organic solvents, facilitating the separation, purification and identification of the components; antimalarial, an antiproliferative agent, an antifungal agent, an antibacterial, or an anti-inflammatory agent
07/07/2005US20050148635 3-imino-2-indolones for the treatment of depression and/or anxiety
07/07/2005US20050148631 Modulation of steroid enzymes in mammals as antidiabetic agents, for treatment of obesity, vision defects, lowering fats in blood, for treatment of osteoporosis, tuberculosis or atherosclerosis in mammals
07/07/2005US20050148627 Benzopyran compounds for use in the treatment and prevention of inflammation related conditions
07/07/2005US20050148623 HIV protease inhibiting compounds
07/07/2005US20050148605 Modulation of protein tyrosine kinases for treatment of diseases with prodrugs
07/07/2005US20050148601 Neurokinin-3 receptor modulators: diaryl imidazole derivatives
07/07/2005US20050148588 LFA-1 antagonist compounds
07/07/2005US20050148581 Quinolines; 1-(6-bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-naphthalen-1-yl-1-phenyl-butan-2-ol; Mycobacterium tuberculosis, M. bovis, M. avium and M. marinum; reduces the total length of treatment and the frequency of drug administration; multi-drug and antibiotic resistance
07/07/2005US20050148574 Imidazole compositions useful as inhibitors of protein kinases
07/07/2005US20050148573 Benzimidazolone compounds having 5-HT4 receptor agonistic activity
07/07/2005US20050148548 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
07/07/2005US20050148086 Fluorescent sensor for phosphate ion and phosphorylated peptide
07/07/2005US20050147905 Electrostatics; high compatibility with the polymeric binder, reduced phase separation, and reduced extraction by liquid carriers
07/07/2005CA2792483A1 Hiv protease inhibiting sulfonamides
07/07/2005CA2550643A1 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof
07/07/2005CA2549651A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
07/07/2005CA2549389A1 Hiv protease inhibiting sulfonamides
07/07/2005CA2549009A1 Opioid receptor antagonists
07/07/2005CA2548824A1 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
07/07/2005CA2548518A1 Biaryl sulfonamides as mmp inhibitors
07/07/2005CA2529314A1 Piperazine derivatives and methods of use
07/06/2005EP1550914A1 Organophotoreceptor with a charge transport material having two epoxidated-hydrazone groups
07/06/2005EP1550727A1 Novel macrophage foam cell formation inhibitor fka-25 and p rocess for producing the same
07/06/2005EP1550668A1 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same
07/06/2005EP1550660A1 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same
07/06/2005EP1550657A1 Amine compounds and use thereof
07/06/2005EP1549646A2 Piperidine derivatives
07/06/2005EP1549627A1 1-phenylalkyl-piperazines
07/06/2005EP1549621A1 Fluorinated phenyl-naphthalenyl-urea compounds as inhibitors of cytokines involved in inflammatory processes
07/06/2005EP1549619A1 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
07/06/2005EP1549614A2 Vasculostatic agents and methods of use thereof
07/06/2005EP1549600A1 Ketones
07/06/2005EP1549316A1 INHIBITORS OF TFG&bgr;
07/06/2005EP1233961B1 Method for producing 5-(1-piperazinyl)-benzofuran-2-carboxamide by transition metal-catalyzed amination
07/06/2005EP1212320B1 Phenylpiperazines as serotonin reuptake inhibitors
07/06/2005EP1140909B1 Novel inhibitors of farnesyl-protein transferase
07/06/2005EP0776327B1 New multimerizing agents
07/06/2005CN1636002A Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide
07/06/2005CN1636001A 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
07/06/2005CN1636000A 5-substituted arylpyrimidines
07/06/2005CN1635903A Protease inhibitors
07/06/2005CN1635890A Neuroprotective 2-pyridinamine compositions and related methods
07/06/2005CN1635885A Improvement of nitric oxide synthase activity by using substituted indole compound
07/06/2005CN1635878A Methods of treating cancer and the pain associated therewith with using endothelin antagonists
07/06/2005CN1634893A 4, 5-disubstituted-1, 8-naphthoyl imide compounds and use thereof
07/06/2005CN1209360C 16-halogen-epothilone derivatives, process for producing them and their pharmaceutical use
07/05/2005US6914160 Oxytocin inhibitors